Resource Centers
Ob/Gyn & Women's Health Journals
Medscape Community Resources
- Maria Rodriguez's Reproductive Write
- Does the Use of Recombinant Human Leukemia Inhibitory Factor Improve IVF Implantation and Pregnancy Rates?
- Efficacy of HPV Vaccine Confirmed for Women Over 25 Years of Age
- Health Services for Low-Income and Uninsured Women
- Mental Health Issues in Pregnancy and Options for Treatment
POLL
A study published last month in the Archives of Internal Medicine reveals primary care practices sometimes do not inform patients of abnormal lab results or do not keep a record of the patient being informed. About 1 of every 14 abnormal tests was not reported to the patient. How likely or not likely is this to happen in your practice?
- ACTONEL® (risedronate sodium tablets)
- DanActive® and ACTIVIA® Information Center
- GARDASIL® [Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant]
- NUCYNTA (tapentadol)
- PREMARIN® (conjugated estrogens tablets, USP)
- Reclast® (zoledronic acid) injection
- The Pain Institute
- VESIcare (solifenacin succinate) tablets
Latest from NAMS at
Medscape.com/NAMS
Medscape.com/NAMS
Advisory Board
- Peter S. Bernstein, MD, MPH, FACOG
- Paul D. Blumenthal, MD, MPH
- William Reid Camann, MD
- Lorraine Dennerstein, AO, MBBS, PhD, DPM, FRANZCP
- Victoria L. Handa, MD, FACOG
- Peter Kovacs, MD
- Susan A. New, BA, MSc, PhD, RPHNutr
- Kathleen I. Pritchard, MD, FRCPC
- Yolanda R. Smith, MD
- Karen Smith-McCune, MD, PhD
Site Editorial Director
Site Editor